We would love to hear your thoughts about our site and services, please take our survey here.
I agree, the volume is small beer and for multiple employees so probably relates to an internal incentive scheme for employees. I don't think we can read anything into this regarding closed periods.
TwoGoodToDie
Obviously it didn't sink in last time because you are still posting the same nonsense (deliberately no doubt).
CLIA approved labs are allowed to use Parsortix to perform laboratory developed tests on ALL cancer types. No need for FDA approval.
2GTD, CLIA approved labs are allowed to use Parsortix to perform laboratory developed tests on ALL cancer types. No need for FDA approval. Let me know if that concept is too complicated for you.
Why not wait until the results in a few weeks, at which point I would expect an update on current trading and outlook, before making such definitive and potentially wrong statements about the commercialisation position ? You will then be able to speak with facts to hand.
One of the risks with the uncontrolled trail is that the doctors involved, through a form of unconscious selection bias, put their 'healthiest' patients on the trial (e.g. patients who haven't had so much treatment that their immune system has become significantly weakened). This could lead to the results being skewed as the trial participants are those that would have responded well to the CPI's on their own. This IMO is one of the reasons that in a small uncontrolled trial it is difficult to be sure exactly what difference the drug has made compared to the performance of CPI's on their own. This bias effect would be eliminated in larger controlled trials, which may well be why we see trials where the drug appears to have had a positive impact in phase 1/2 but then fails in phase 3.
Having said this, the results so far have been so good that I'd be very surprised if SCIB1 wasn't having a materially positive impact.
Given that the AACR presentation by LD in April wasn't mentioned in the RNS this leads me to think that we may get a separate RNS for that one with an update on recruitment, patient progress etc. Here's hoping.